OPEN Research Support

Bjørn Stæhr Madsen
Department of Medical Gastroenterology, Odense University Hospital

Projekt styring
Projekt status    Sampling ongoing
Data indsamlingsdatoer
Start 01.01.2015  
Slut 31.12.2017  

Anti-fibrotic and molecular aspects of rifaximin in alcoholic liver disease

Short summary

This project is part of the GALAXY consortium (Gut-and-liver-axis in alcoholic liver fibrosis), which is exploring the role of the gut microbiome in alcoholic liver fibrosis to improve understanding, diagnosis, prevention and treatment of chronic liver disease. Additionally, the following projects are also a part of the GALAXY consortium: OP_40 and OP_239.